首页> 外国专利> ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR).

ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR).

机译:ALPHA取代的OMEGA-3脂质,是过氧化物酶增殖物活化受体(PPAR)的活化剂或调节剂。

摘要

Omega-3 lipid compounds of the general formula (I): wherein R1 and R2 are the same or different and may be selected from a group of substituents consisting of hydrogen, a hydroxy group, an alkyl group, a halogen atom, an alkoxy group, an acyloxy group, an acyl group, an alkenyl group, an alkynyl group, an aryl group, an alkylthio group, an alkoxycarbonyl group, a carboxy group, an alkylsulfinyl group, an alkylsulfonyl group, an amino group, and an alkylamino group; X represents a carboxylic acid or a derivative thereof, a carboxylate, a carboxylic anhydride or a carboxamide; and Y is a C6 to C22 alkene with two or more double bonds, having E and/or Z configuration, are disclosed. Also disclosed are pharmaceutical compositions and lipid compositions comprising such compounds, and to such compounds for use as medicaments in particular for the treatment of cardiovascular and metabolic diseases.
机译:通式(I)的Omega-3脂质化合物:其中R1和R2是相同或不同的,并且可以选自氢,羟基,烷基,卤素原子,烷氧基组成的一组取代基,酰氧基,酰基,烯基,炔基,芳基,烷硫基,烷氧基羰基,羧基,烷基亚磺酰基,烷基磺酰基,氨基和烷基氨基; X代表羧酸或其衍生物,羧酸盐,羧酸酐或羧酰胺;并且公开了Y为具有两个或多个具有E和/或Z构型的双键的C 6至C 22烯烃。还公开了包含这样的化合物的药物组合物和脂质组合物,并且还公开了这样的化合物,其用作药物,特别是用于治疗心血管和代谢疾病。

著录项

  • 公开/公告号EP2094640A4

    专利类型

  • 公开/公告日2015-05-20

    原文格式PDF

  • 申请/专利权人 PRONOVA BIOPHARMA NORGE AS;

    申请/专利号EP20070825558

  • 申请日2007-11-01

  • 分类号C07C69/587;A61K31/202;A61K31/232;A61K49;A61P1/16;A61P3/04;A61P3/10;A61P29;C07C57/13;C07C69/602;C07C69/732;C07C69/734;C07C229/30;C07C323/54;C11C3;

  • 国家 EP

  • 入库时间 2022-08-21 15:08:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号